Click for best price
Stem Cell Therapy for Osteoarthritis Market Size, Share 2023
| Market size in 2022 |
US$ 23 million
|
Forecast Market size by 2029 |
US$ 102.2 million
|
| Growth Rate |
CAGR of 24.0% |
Number of Pages |
69 Pages |
OA is the most common degenerative joint disease. Its initial symptoms include loss of articular cartilage followed by progressive to joint stiffness, swelling, pain, and loss of mobility.
Stem cells are the body's raw materials ? cells from which all other cells with specialized functions are generated. Under the right conditions in the body or a laboratory, stem cells divide to form more cells called daughter cells. These daughter cells either become new stem cells (self-renewal) or become specialized cells (differentiation) with a more specific function, such as blood cells, brain cells, heart muscle cells or bone cells. No other cell in the body has the natural ability to generate new cell types.
Most stem cells used for the experimental treatment of OA are adult MSCs. Researchers can easily collect them from fat or bone marrow. MSCs are able to turn into cartilage, bone, muscle, tendon, ligaments, or fat, depending on the type of tissue that surrounds them. This is why researchers are studying MSCs in stem cell treatments for OA.
This report aims to provide a comprehensive presentation of the global market for Stem Cell Therapy for Osteoarthritis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cell Therapy for Osteoarthritis. This report contains market size and forecasts of Stem Cell Therapy for Osteoarthritis in global, including the following market information:
Global Stem Cell Therapy for Osteoarthritis Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Stem Cell Therapy for Osteoarthritis market was valued at US$ 23 million in 2022 and is projected to reach US$ 102.2 million by 2029, at a CAGR of 24.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In the global market, the core manufacturers of Stem cell therapy for osteoarthritis include Medipost etc, and the top 1 manufacturer accounts for about 80% of the market share. The market include Asia Pacific and Europe, with a share of 90% and 10%. allogeneic accounted for 90% and autologous accounted for 10%. the product is mainly used in primary osteoarthritis and secondary osteoarthritis fields, with a share of 92% and 8%.
We surveyed the Stem Cell Therapy for Osteoarthritis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Stem Cell Therapy for Osteoarthritis Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Stem Cell Therapy for Osteoarthritis Market Segment Percentages, by Type, 2022 (%)
Allogeneic
Autologous
Global Stem Cell Therapy for Osteoarthritis Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Stem Cell Therapy for Osteoarthritis Market Segment Percentages, by Application, 2022 (%)
Primary Osteoarthritis
Secondary Osteoarthritis
Global Stem Cell Therapy for Osteoarthritis Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Stem Cell Therapy for Osteoarthritis Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Stem Cell Therapy for Osteoarthritis revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Stem Cell Therapy for Osteoarthritis revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medipost
Nature Cell
Theracell Advanced Biotechnology
Takeda (TiGenix)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Stem Cell Therapy for Osteoarthritis, market overview.
Chapter 2: Global Stem Cell Therapy for Osteoarthritis market size in revenue.
Chapter 3: Detailed analysis of Stem Cell Therapy for Osteoarthritis company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Stem Cell Therapy for Osteoarthritis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Stem Cell Therapy for Osteoarthritis Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 23 million
|
| Forecast Market size by 2029 |
US$ 102.2 million
|
| Growth Rate |
CAGR of 24.0% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
69 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Stem Cell Therapy for Osteoarthritis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Stem Cell Therapy for Osteoarthritis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Stem Cell Therapy for Osteoarthritis Overall Market Size
2.1 Global Stem Cell Therapy for Osteoarthritis Market Size: 2022 VS 2029
2.2 Global Stem Cell Therapy for Osteoarthritis Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Stem Cell Therapy for Osteoarthritis Players in Global Market
3.2 Top Global Stem Cell Therapy for Osteoarthritis Companies Ranked by Revenue
3.3 Global Stem Cell Therapy for Osteoarthritis Revenue by Companies
3.4 Top 3 and Top 5 Stem Cell Therapy for Osteoarthritis Companies in Global Market, by Revenue in 2022
3.5 Global Companies Stem Cell Therapy for Osteoarthritis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Stem Cell Therapy for Osteoarthritis Players in Global Market
3.6.1 List of Global Tier 1 Stem Cell Therapy for Osteoarthritis Companies
3.6.2 List of Global Tier 2 and Tier 3 Stem Cell Therapy for Osteoarthritis Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Stem Cell Therapy for Osteoarthritis Market Size Markets, 2022 & 2029
4.1.2 Allogeneic
4.1.3 Autologous
4.2 By Type - Global Stem Cell Therapy for Osteoarthritis Revenue & Forecasts
4.2.1 By Type - Global Stem Cell Therapy for Osteoarthritis Revenue, 2018-2023
4.2.2 By Type - Global Stem Cell Therapy for Osteoarthritis Revenue, 2024-2029
4.2.3 By Type - Global Stem Cell Therapy for Osteoarthritis Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Stem Cell Therapy for Osteoarthritis Market Size, 2022 & 2029
5.1.2 Primary Osteoarthritis
5.1.3 Secondary Osteoarthritis
5.2 By Application - Global Stem Cell Therapy for Osteoarthritis Revenue & Forecasts
5.2.1 By Application - Global Stem Cell Therapy for Osteoarthritis Revenue, 2018-2023
5.2.2 By Application - Global Stem Cell Therapy for Osteoarthritis Revenue, 2024-2029
5.2.3 By Application - Global Stem Cell Therapy for Osteoarthritis Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Stem Cell Therapy for Osteoarthritis Market Size, 2022 & 2029
6.2 By Region - Global Stem Cell Therapy for Osteoarthritis Revenue & Forecasts
6.2.1 By Region - Global Stem Cell Therapy for Osteoarthritis Revenue, 2018-2023
6.2.2 By Region - Global Stem Cell Therapy for Osteoarthritis Revenue, 2024-2029
6.2.3 By Region - Global Stem Cell Therapy for Osteoarthritis Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Stem Cell Therapy for Osteoarthritis Revenue, 2018-2029
6.3.2 US Stem Cell Therapy for Osteoarthritis Market Size, 2018-2029
6.3.3 Canada Stem Cell Therapy for Osteoarthritis Market Size, 2018-2029
6.3.4 Mexico Stem Cell Therapy for Osteoarthritis Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Stem Cell Therapy for Osteoarthritis Revenue, 2018-2029
6.4.2 Germany Stem Cell Therapy for Osteoarthritis Market Size, 2018-2029
6.4.3 France Stem Cell Therapy for Osteoarthritis Market Size, 2018-2029
6.4.4 U.K. Stem Cell Therapy for Osteoarthritis Market Size, 2018-2029
6.4.5 Italy Stem Cell Therapy for Osteoarthritis Market Size, 2018-2029
6.4.6 Russia Stem Cell Therapy for Osteoarthritis Market Size, 2018-2029
6.4.7 Nordic Countries Stem Cell Therapy for Osteoarthritis Market Size, 2018-2029
6.4.8 Benelux Stem Cell Therapy for Osteoarthritis Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Stem Cell Therapy for Osteoarthritis Revenue, 2018-2029
6.5.2 China Stem Cell Therapy for Osteoarthritis Market Size, 2018-2029
6.5.3 Japan Stem Cell Therapy for Osteoarthritis Market Size, 2018-2029
6.5.4 South Korea Stem Cell Therapy for Osteoarthritis Market Size, 2018-2029
6.5.5 Southeast Asia Stem Cell Therapy for Osteoarthritis Market Size, 2018-2029
6.5.6 India Stem Cell Therapy for Osteoarthritis Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Stem Cell Therapy for Osteoarthritis Revenue, 2018-2029
6.6.2 Brazil Stem Cell Therapy for Osteoarthritis Market Size, 2018-2029
6.6.3 Argentina Stem Cell Therapy for Osteoarthritis Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Stem Cell Therapy for Osteoarthritis Revenue, 2018-2029
6.7.2 Turkey Stem Cell Therapy for Osteoarthritis Market Size, 2018-2029
6.7.3 Israel Stem Cell Therapy for Osteoarthritis Market Size, 2018-2029
6.7.4 Saudi Arabia Stem Cell Therapy for Osteoarthritis Market Size, 2018-2029
6.7.5 UAE Stem Cell Therapy for Osteoarthritis Market Size, 2018-2029
7 Stem Cell Therapy for Osteoarthritis Companies Profiles
7.1 Medipost
7.1.1 Medipost Company Summary
7.1.2 Medipost Business Overview
7.1.3 Medipost Stem Cell Therapy for Osteoarthritis Major Product Offerings
7.1.4 Medipost Stem Cell Therapy for Osteoarthritis Revenue in Global Market (2018-2023)
7.1.5 Medipost Key News & Latest Developments
7.2 Nature Cell
7.2.1 Nature Cell Company Summary
7.2.2 Nature Cell Business Overview
7.2.3 Nature Cell Stem Cell Therapy for Osteoarthritis Major Product Offerings
7.2.4 Nature Cell Stem Cell Therapy for Osteoarthritis Revenue in Global Market (2018-2023)
7.2.5 Nature Cell Key News & Latest Developments
7.3 Theracell Advanced Biotechnology
7.3.1 Theracell Advanced Biotechnology Company Summary
7.3.2 Theracell Advanced Biotechnology Business Overview
7.3.3 Theracell Advanced Biotechnology Stem Cell Therapy for Osteoarthritis Major Product Offerings
7.3.4 Theracell Advanced Biotechnology Stem Cell Therapy for Osteoarthritis Revenue in Global Market (2018-2023)
7.3.5 Theracell Advanced Biotechnology Key News & Latest Developments
7.4 Takeda (TiGenix)
7.4.1 Takeda (TiGenix) Company Summary
7.4.2 Takeda (TiGenix) Business Overview
7.4.3 Takeda (TiGenix) Stem Cell Therapy for Osteoarthritis Major Product Offerings
7.4.4 Takeda (TiGenix) Stem Cell Therapy for Osteoarthritis Revenue in Global Market (2018-2023)
7.4.5 Takeda (TiGenix) Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Stem Cell Therapy for Osteoarthritis Market Opportunities & Trends in Global Market
Table 2. Stem Cell Therapy for Osteoarthritis Market Drivers in Global Market
Table 3. Stem Cell Therapy for Osteoarthritis Market Restraints in Global Market
Table 4. Key Players of Stem Cell Therapy for Osteoarthritis in Global Market
Table 5. Top Stem Cell Therapy for Osteoarthritis Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Stem Cell Therapy for Osteoarthritis Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Stem Cell Therapy for Osteoarthritis Revenue Share by Companies, 2018-2023
Table 8. Global Companies Stem Cell Therapy for Osteoarthritis Product Type
Table 9. List of Global Tier 1 Stem Cell Therapy for Osteoarthritis Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Stem Cell Therapy for Osteoarthritis Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Stem Cell Therapy for Osteoarthritis Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Stem Cell Therapy for Osteoarthritis Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Stem Cell Therapy for Osteoarthritis Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Stem Cell Therapy for Osteoarthritis Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Stem Cell Therapy for Osteoarthritis Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Stem Cell Therapy for Osteoarthritis Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2024-2029
Table 30. Medipost Company Summary
Table 31. Medipost Stem Cell Therapy for Osteoarthritis Product Offerings
Table 32. Medipost Stem Cell Therapy for Osteoarthritis Revenue (US$, Mn) & (2018-2023)
Table 33. Medipost Key News & Latest Developments
Table 34. Nature Cell Company Summary
Table 35. Nature Cell Stem Cell Therapy for Osteoarthritis Product Offerings
Table 36. Nature Cell Stem Cell Therapy for Osteoarthritis Revenue (US$, Mn) & (2018-2023)
Table 37. Nature Cell Key News & Latest Developments
Table 38. Theracell Advanced Biotechnology Company Summary
Table 39. Theracell Advanced Biotechnology Stem Cell Therapy for Osteoarthritis Product Offerings
Table 40. Theracell Advanced Biotechnology Stem Cell Therapy for Osteoarthritis Revenue (US$, Mn) & (2018-2023)
Table 41. Theracell Advanced Biotechnology Key News & Latest Developments
Table 42. Takeda (TiGenix) Company Summary
Table 43. Takeda (TiGenix) Stem Cell Therapy for Osteoarthritis Product Offerings
Table 44. Takeda (TiGenix) Stem Cell Therapy for Osteoarthritis Revenue (US$, Mn) & (2018-2023)
Table 45. Takeda (TiGenix) Key News & Latest Developments
List of Figures
Figure 1. Stem Cell Therapy for Osteoarthritis Segment by Type in 2022
Figure 2. Stem Cell Therapy for Osteoarthritis Segment by Application in 2022
Figure 3. Global Stem Cell Therapy for Osteoarthritis Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Stem Cell Therapy for Osteoarthritis Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Stem Cell Therapy for Osteoarthritis Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Stem Cell Therapy for Osteoarthritis Revenue in 2022
Figure 8. By Type - Global Stem Cell Therapy for Osteoarthritis Revenue Market Share, 2018-2029
Figure 9. By Application - Global Stem Cell Therapy for Osteoarthritis Revenue Market Share, 2018-2029
Figure 10. By Type - Global Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Stem Cell Therapy for Osteoarthritis Revenue Market Share, 2018-2029
Figure 12. By Application - Global Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Stem Cell Therapy for Osteoarthritis Revenue Market Share, 2018-2029
Figure 14. By Region - Global Stem Cell Therapy for Osteoarthritis Revenue Market Share, 2018-2029
Figure 15. By Country - North America Stem Cell Therapy for Osteoarthritis Revenue Market Share, 2018-2029
Figure 16. US Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Stem Cell Therapy for Osteoarthritis Revenue Market Share, 2018-2029
Figure 20. Germany Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2018-2029
Figure 21. France Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Stem Cell Therapy for Osteoarthritis Revenue Market Share, 2018-2029
Figure 28. China Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2018-2029
Figure 32. India Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Stem Cell Therapy for Osteoarthritis Revenue Market Share, 2018-2029
Figure 34. Brazil Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Stem Cell Therapy for Osteoarthritis Revenue Market Share, 2018-2029
Figure 37. Turkey Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Stem Cell Therapy for Osteoarthritis Revenue, (US$, Mn), 2018-2029
Figure 41. Medipost Stem Cell Therapy for Osteoarthritis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Nature Cell Stem Cell Therapy for Osteoarthritis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Theracell Advanced Biotechnology Stem Cell Therapy for Osteoarthritis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Takeda (TiGenix) Stem Cell Therapy for Osteoarthritis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
